CompletedPhase 2NCT00975819
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Studying Isolated rare lymphatic malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Denise Martin Adams
- Principal Investigator
- Denise M Adams, MDChildren's Hospital Medical Center, Cincinnati
- Intervention
- sirolimus(drug)
- Enrollment
- 61 enrolled
- Eligibility
- 31 years · All sexes
- Timeline
- 2009 – 2020
Study locations (2)
- Children's Hospital Boston, Boston, Massachusetts, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Collaborators
Children's Hospital Medical Center, Cincinnati
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00975819 on ClinicalTrials.gov